HomeREGULATORY
REGULATORY

MHLW Orders Label Revisions for Otezla, Ceftriaxone
(Aug.3.2018)

The Ministry of Health, Labor and Welfare (MHLW) issued a notification on August 2 ordering label revisions for Celgene’s psoriasis treatment Otezla (apremilast) and Taiyo Pharma’s Rocephin (ceftriaxone sodium hydrate) and its generics ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar